Melanoma Clinical Trials in Clermont-Ferrand
2 recruitingClermont-Ferrand, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Triple-Negative Breast CancerCervical CancerUrothelial Carcinoma+12 more
UNICANCER646 enrolled40 locationsNCT05078047
Recruiting
Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
Melanoma Metastatic
Centre Hospitalier Universitaire de Besancon77 enrolled9 locationsNCT06586593